Research progress on the predictive role of serum Krebs von den Lungen-6 in pulmonary diseases
10.20001/j.issn.2095-2619.20230218
- VernacularTitle:血清涎液化糖链抗原6对肺部疾病预警作用研究进展
- Author:
Xuehua ZHU
1
;
Yiru QIN
;
Qiying NONG
;
Yongshun HUANG
;
Na ZHAO
;
Lihua XIA
Author Information
1. School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
- Publication Type:Review
- Keywords:
Krebs von den Lungen-6;
Diagnosis;
Biomarkers;
Interstitial lung disease;
Lung cancer;
Pneumonia;
Chronic obstructive pulmonary disease;
Pneumoconiosis
- From:
China Occupational Medicine
2023;50(1):104-109
- CountryChina
- Language:Chinese
-
Abstract:
Early diagnosis of pulmonary diseases is of great significance for their prevention and treatment. Serum Krebs von den Lungen-6 (KL-6) assay can reflect the damage degree of alveolar epithelium and stromal tissue, and is simple, non-invasive and low-cost. Pervious study showed that the serum KL-6 level was higher in patients with various interstitial lung diseases (e.g. idiopathic pulmonary fibrosis and connective tissue disease, primary Sjögren's syndrome, rheumatoid arthritis, idiopathic inflammatory myopathy and systemic sclerosis combined with interstitial lung disease), non-small cell lung cancer, various pneumonias and chronic obstructive pulmonary disease compared to healthy controls. Therefore, serum KL-6 has good sensitivity and specificity for the early diagnosis of these diseases. Occupational pneumoconiosis is an interstitial lung disease with a well-established etiology. Pervious study has shown that serum KL-6 level was higher in patients with occupational silicosis, occupational asbestosis, and dust-exposed workers compared to healthy controls. However, due to the limited sample size and the inconsistent findings on different studies, further research is needed to study the role of serum KL-6 in the early diagnosis of pneumoconiosis. Future studies should increase the sample size, improve the detection methods for serum KL-6, explore its feasibility as an early diagnostic biomarker for occupational pulmonary diseases, and investigate the efficacy andvalue of its combined application with other biomarkers in the early diagnosis of various pulmonary diseases, including occupational lung diseases, to fully exploit its predictive role in pulmonary diseases.
